Researchers sought to determine the incidence, patterns of disease progression, and outcomes of melanoma brain metastases (MBM) in patients treated with anti–PD-1 immunotherapy.
Scientific Publications
Patients’ views about skin self-examination after treatment for localized melanoma
Via a qualitative interview study among 37 patients with localized melanoma (American Joint Committee on Cancer stage 0, I, or II), researchers investigated the views of patients with melanoma regarding skin self-examination (SSE) in general, as well as their attitudes toward using novel digital technologies to support their own SSE.
Five-year outcomes with dabrafenib plus trametinib in metastatic melanoma
Pooled extended-survival data from two trials including formerly untreated 563 patients who had received BRAF inhibitor dabrafenib plus MEK inhibitor trametinib in the COMBI-d and COMBI-v trials were investigated by the experts in order to determine, in metastatic melanoma, five-year outcomes with dabrafenib plus trametinib.
No association between smoking and sentinel lymph node metastasis and survival in cutaneous melanoma
This retrospective cohort study was undertaken to determine if smoking was correlated with a higher rate of sentinel lymph node (SLN) metastasis and worse survival in cutaneous melanoma patients using a propensity score matching analysis.